您的位置: 首页 > 农业专利 > 详情页

Treatment of cancer with dihydropyrazino-pyrazines
专利权人:
LLC;Signal Pharmaceuticals
发明人:
Heather Raymon,Kristen Mae Hege
申请号:
US14254004
公开号:
US09630966B2
申请日:
2014.04.16
申请国别(地区):
US
年份:
2017
代理人:
摘要:
Provided herein are methods for treating or preventing glioblastoma multiforme (GBM) characterized by O6-methylguanine-DNA methyltransferase (MGMT) expression and/or promoter methylation status, comprising administering an effective amount of a Dihydropyrazino-Pyrazine Compound to a patient having glioblastoma multiforme (GBM) characterized by O6-methylguanine-DNA methyltransferase (MGMT) expression and/or promoter methylation status.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充